Duck Viral Enteritis (Duck Plague): Etiology, Clinical Signs, and Control
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Duck Viral Enteritis (DVE), or duck plague, is caused by Anatid herpesvirus 1 (AnHV-1), a highly contagious alphaherpesvirus affecting waterfowl. Transmission occurs horizontally through direct contact, contaminated water, and fomites, with infected birds shedding the virus in feces and secretions.
- Clinical signs are acute and severe, characterized by sudden death, depression, anorexia, polydipsia, photophobia, ataxia, and hemorrhagic diarrhea with cloacal discharge, leading to high morbidity and mortality rates (up to 90-100%).
- Gross pathology includes widespread vascular damage, hemorrhages (petechiae and ecchymoses) on organs and serosal surfaces, enlarged and friable livers with necrotic foci, and severe hemorrhagic enteritis with diphtheritic membranes.
- Diagnosis relies on rapid molecular methods such as real-time PCR and RPA targeting the UL2 gene, alongside virus isolation in cell cultures (DEFs/CEFs) and confirmatory serological tests like ELISA and serum neutralization for antibody detection.
- Control strategies primarily involve vaccination with live attenuated vaccines, often developed through serial passage or targeted gene deletion (e.g., UL2, UL50, ICP27), and strict biosecurity measures including quarantine, disinfection, and proper carcass disposal.
- Recombinant vaccines are being developed as multivalent vectors to provide simultaneous protection against DVE and other waterfowl pathogens, with some ICP27 deletion marker vaccines enabling DIVA (differentiation of infected from vaccinated animals) strategies.
Introduction
Duck viral enteritis (DVE), commonly known as duck plague, is an acute, highly contagious viral disease affecting waterfowl, particularly ducks, geese, and swans [<a href="#ref-1">1</a>]. The disease is caused by Anatid herpesvirus 1 (AnHV-1), a member of the subfamily Alphaherpesvirinae within the family Herpesviridae [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. DVE is characterized by sudden onset, high morbidity and mortality, vascular damage, hemorrhagic lesions, and necrosis of lymphoid tissues and gastrointestinal mucosa [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The term "what is ducks disease" often refers to this devastating condition, which remains a major threat to domestic and wild waterfowl populations worldwide [<a href="#ref-1">1</a>]. This article provides a detailed, publication-grade review of the etiology, epidemiology, clinical signs, pathology, diagnostics, treatment, and control of DVE, with dense citations from the peer-reviewed literature.
Etiology
The causative agent of DVE is Anatid herpesvirus 1 (AnHV-1), a double-stranded DNA virus with a genome of approximately 150-160 kbp [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. The virion is enveloped and icosahedral, with a diameter of 150-200 nm [<a href="#ref-6">6</a>]. The genome encodes numerous structural and non-structural proteins involved in replication, immune evasion, and pathogenesis [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. Key viral proteins include UL50, which is essential for replication and pathogenesis [<a href="#ref-7">7</a>]; UL24, which initiates K48/K63-linked polyubiquitination of IRF7 to antagonize innate immunity [<a href="#ref-9">9</a>]; US3, a protein kinase that phosphorylates interferon regulatory factor 7 to inhibit DNA sensing [<a href="#ref-10">10</a>]; and VP26, which interacts with the host actin-myosin II network to regulate viral proliferation [<a href="#ref-8">8</a>]. The UL2 gene has been identified as a virulence determinant; deletion of UL2 attenuates pathogenicity and restores gut microbiota balance [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. Variants with deletions in UL2 have been isolated from geese and ducks in China [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>]. The complete genome sequences of several virulent and attenuated strains have been determined, facilitating molecular characterization and vaccine development [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>, <a href="#ref-6">6</a>].
Epidemiology
DVE occurs in both domestic and wild waterfowl, including ducks, geese, and swans [<a href="#ref-1">1</a>]. Outbreaks have been reported in Asia, Europe, North America, and Australia [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease is most common in adult birds during the breeding season, but all ages are susceptible [<a href="#ref-4">4</a>]. Transmission occurs horizontally via direct contact with infected birds or contaminated water and fomites [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. The virus is shed in feces, oral secretions, and on feathers [<a href="#ref-5">5</a>]. Vertical transmission has not been conclusively demonstrated. Recovered birds can become latent carriers and intermittently shed virus under stress [<a href="#ref-14">14</a>]. The virus can survive in water for several days, facilitating rapid spread within flocks and across wetlands [<a href="#ref-13">13</a>]. Outbreaks in vaccinated flocks have been reported, indicating the emergence of virulent strains that can overcome vaccine-induced immunity [<a href="#ref-4">4</a>]. A novel variant derived from geese with a deletion in UL2 has shown altered pathogenicity and shedding patterns [<a href="#ref-5">5</a>]. Non-target species such as chickens can be infected experimentally but do not typically develop clinical disease [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>].
Clinical Signs
The incubation period ranges from 3 to 7 days [<a href="#ref-4">4</a>]. Clinical signs vary with virus strain, host age, and immune status. Acute cases present with sudden death without premonitory signs [<a href="#ref-1">1</a>]. In peracute and acute forms, affected birds exhibit depression, anorexia, polydipsia, photophobia, and ataxia [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. Ocular and nasal discharges are common [<a href="#ref-1">1</a>]. Diarrhea is a hallmark sign; feces may be watery, greenish, or blood-tinged [<a href="#ref-5">5</a>]. Hemorrhagic cloacal discharge is frequently observed [<a href="#ref-1">1</a>]. In laying ducks, egg production drops sharply [<a href="#ref-4">4</a>]. Mortality rates can reach 90-100% in susceptible flocks [<a href="#ref-5">5</a>]. Subacute and chronic cases show progressive emaciation and weakness [<a href="#ref-1">1</a>]. The clinical presentation is summarized in Table 1.
Table 1. Clinical Signs of Duck Viral Enteritis by Disease Form
| Disease Form | Clinical Signs |
|---|---|
| Peracute | Sudden death, no premonitory signs [<a href="#ref-1">1</a>] |
| Acute | Depression, anorexia, polydipsia, photophobia, ataxia, ocular/nasal discharge, greenish or bloody diarrhea, cloacal hemorrhage, egg drop [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>, <a href="#ref-5">5</a>] |
| Subacute | Emaciation, weakness, persistent diarrhea, dehydration [<a href="#ref-5">5</a>] |
| Chronic | Cachexia, intermittent diarrhea, secondary infections [<a href="#ref-1">1</a>] |
Pathology
Gross lesions are characteristic and include vascular damage, hemorrhages, and necrosis. Petechiae and ecchymoses are present on the heart, liver, pancreas, and serosal surfaces [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The liver is enlarged, friable, and may have pale necrotic foci [<a href="#ref-1">1</a>]. The spleen is often mottled and enlarged [<a href="#ref-5">5</a>]. The gastrointestinal tract shows severe hemorrhagic enteritis, with mucosal erosions and diphtheritic membranes in the esophagus, ceca, and cloaca [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>]. The bursa of Fabricius and thymus are atrophied [<a href="#ref-5">5</a>]. Histopathological findings include intranuclear inclusion bodies in hepatocytes, enterocytes, and lymphoid cells [<a href="#ref-4">4</a>]. Necrosis of lymphoid tissues and vasculitis are prominent [<a href="#ref-5">5</a>]. The virus induces apoptosis in intestinal epithelial cells, which can be alleviated by poly I:C treatment [<a href="#ref-15">15</a>]. Proteomic studies have revealed that VP26 interacts with the host actin-myosin II network, facilitating viral egress [<a href="#ref-8">8</a>].
Diagnostics
Rapid and accurate diagnosis is essential for outbreak control. Several molecular and serological methods are available.
Molecular Detection
Real-time PCR and recombinase polymerase amplification (RPA) assays have been developed for rapid detection of AnHV-1 [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. A real-time fluorescence RPA method targeting the UL2 gene can differentiate virulent from vaccine strains [<a href="#ref-16">16</a>]. Multienzyme isothermal rapid amplification (MIRA) combined with quantitative PCR or lateral flow dipsticks provides field-deployable detection [<a href="#ref-17">17</a>]. A visual gene chip method allows simultaneous detection of DVE virus along with six other waterfowl pathogens [<a href="#ref-18">18</a>]. Conventional PCR and sequencing are used for genotyping and phylogenetic analysis [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>].
Virus Isolation
Virus isolation can be performed in duck embryo fibroblasts (DEFs) or chicken embryo fibroblasts (CEFs) [<a href="#ref-19">19</a>]. Cytopathic effects (CPE) appear within 48-72 hours, characterized by rounding, detachment, and syncytia formation [<a href="#ref-19">19</a>]. Isolates can be confirmed by immunofluorescence or PCR [<a href="#ref-4">4</a>].
Serology
Serum neutralization (SN) and enzyme-linked immunosorbent assays (ELISA) are used to detect antibodies [<a href="#ref-19">19</a>]. However, serology is less useful for acute diagnosis due to the rapid course of disease.
Differential Diagnosis
DVE must be differentiated from other causes of hemorrhagic enteritis and sudden death in waterfowl, including avian influenza, Newcastle disease, duck hepatitis A virus, and bacterial septicemias such as fowl cholera and Riemerella anatipestifer infection [<a href="#ref-1">1</a>, <a href="#ref-18">18</a>]. A diagnostic workflow is presented in Figure 1.
flowchart TD
A["Clinical suspicion: sudden death, hemorrhagic diarrhea, cloacal discharge"] --> B{"Postmortem examination"}
B --> C["Gross lesions: liver necrosis, hemorrhagic enteritis, diphtheritic membranes"]
C --> D["Collect samples: liver, spleen, intestinal mucosa, cloacal swabs"]
D --> E{"Molecular detection"}
E --> F["Real-time PCR / RPA / MIRA"]
F --> G["Positive for AnHV-1?"]
G -->|"Yes"| H["Confirmed DVE"]
G -->|"No"| I["Virus isolation in DEF/CEF"]
I --> J["CPE observed?"]
J -->|"Yes"| K["Confirm by PCR or IF"]
J -->|"No"| L["Consider other pathogens: AIV, NDV, DHAV, Pasteurella"]
K --> H
L --> M["Further testing: gene chip, sequencing"]Figure 1. Diagnostic workflow for duck viral enteritis.
Treatment
No specific antiviral therapy is approved for DVE. Supportive care includes fluid therapy, nutritional support, and broad-spectrum antibiotics to control secondary bacterial infections [<a href="#ref-15">15</a>]. In vitro studies have shown that piperazine, an anthelmintic, can inhibit AnHV-1 replication by modulating host cytokine responses [<a href="#ref-20">20</a>]. Chlorogenic acid has been demonstrated to alter gene expression in infected DEFs, suggesting potential antiviral activity [<a href="#ref-21">21</a>]. However, these compounds have not been evaluated in clinical field trials. Vaccination remains the primary control measure.
Control
Vaccination
Live attenuated vaccines are widely used to prevent DVE [<a href="#ref-11">11</a>, <a href="#ref-19">19</a>, <a href="#ref-22">22</a>]. Attenuated strains are produced by serial passage in cell culture or by targeted gene deletion [<a href="#ref-11">11</a>, <a href="#ref-22">22</a>, <a href="#ref-23">23</a>]. Deletion of virulence genes such as UL2, UL50, or ICP27 results in safe and immunogenic vaccine candidates [<a href="#ref-7">7</a>, <a href="#ref-11">11</a>, <a href="#ref-22">22</a>]. A live attenuated vaccine developed in India using CEFs provided robust protection [<a href="#ref-19">19</a>]. Recombinant DVE viruses expressing foreign antigens (e.g., duck hepatitis A virus 3 immunogenic genes, influenza hemagglutinin, Pasteurella multocida OmpH, Chlamydia psittaci Pmp17G) have been constructed as bivalent or multivalent vectors [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>, <a href="#ref-26">26</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>]. CRISPR/Cas9 editing has been employed to insert foreign genes at specific loci [<a href="#ref-26">26</a>, <a href="#ref-28">28</a>]. Recombinant vaccines expressing P. multocida OmpH induce simultaneous protection against duck plague and fowl cholera [<a href="#ref-27">27</a>]. The ICP27 deletion marker vaccine allows serological differentiation of infected from vaccinated animals (DIVA) [<a href="#ref-22">22</a>]. Vaccine safety has been evaluated in non-target species; horizontal transmission to chickens is minimal [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. However, outbreaks in vaccinated flocks highlight the need for continuous surveillance and vaccine strain updates [<a href="#ref-4">4</a>].
Biosecurity
Strict biosecurity measures are essential to prevent introduction and spread. These include quarantine of new birds, disinfection of equipment and footwear, control of wild waterfowl access, and proper disposal of carcasses [<a href="#ref-1">1</a>]. Infected flocks should be depopulated, and premises thoroughly cleaned and disinfected [<a href="#ref-4">4</a>]. The virus is susceptible to lipid solvents, heat, and common disinfectants [<a href="#ref-1">1</a>].
Surveillance
Molecular surveillance using real-time PCR and sequencing helps detect emerging variants and monitor vaccine efficacy [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-16">16</a>]. Gene chip methods enable simultaneous screening for multiple waterfowl pathogens [<a href="#ref-18">18</a>]. Outbreak investigations should include virus isolation and genetic characterization [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>].
Conclusion
Duck viral enteritis remains a significant threat to waterfowl health worldwide. Advances in molecular diagnostics, genomics, and recombinant vaccine technology have improved our ability to detect, characterize, and control the disease. Continued research into viral pathogenesis, host immune responses, and vaccine vector development is essential for sustainable management. The integration of rapid point-of-care diagnostics, DIVA-compatible vaccines, and robust biosecurity protocols will be critical for reducing the impact of DVE in domestic and wild waterfowl populations.